Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Accured Expenses (2016 - 2026)

Myriad Genetics has reported Change in Accured Expenses over the past 17 years, most recently at -$6.7 million for Q4 2025.

  • Quarterly Change in Accured Expenses rose 75.64% to -$6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$27.5 million through Dec 2025, up 32.93% year-over-year, with the annual reading at -$27.5 million for FY2025, 32.93% up from the prior year.
  • Change in Accured Expenses was -$6.7 million for Q4 2025 at Myriad Genetics, down from $8.4 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $71.9 million in Q2 2023 and troughed at -$59.4 million in Q4 2023.
  • The 5-year median for Change in Accured Expenses is -$6.0 million (2023), against an average of -$3.1 million.
  • Year-over-year, Change in Accured Expenses plummeted 7000.0% in 2021 and then surged 4340.0% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$14.2 million in 2021, then surged by 80.28% to -$2.8 million in 2022, then plummeted by 2021.43% to -$59.4 million in 2023, then soared by 53.7% to -$27.5 million in 2024, then soared by 75.64% to -$6.7 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Change in Accured Expenses are -$6.7 million (Q4 2025), $8.4 million (Q3 2025), and -$16.8 million (Q2 2025).